Jared Bunker is a litigation partner in the firm’s Orange County office. He represents clients in state and district courts throughout the country, as well as before the U.S. Court of Appeals for the Federal Circuit and the U.S. Patent Trial and Appeal Board. His primary focus is patent litigation in the pharmaceutical, automotive, and medical device fields.
Mr. Bunker was elected by Knobbe Martens’ Litigation Practice Group to serve as a member of the firm’s Executive Committee. Mr. Bunker has held other leadership roles at the firm.
Education
University of California - Los Angeles (UCLA)
(J.D., 2006)
Brigham Young University
(B.S. Chemistry, 2003), National Society of Collegiate Scholars, Phi Beta Kappa, magna cum laude
Practice Areas
Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited, 21-900-RGA (D. Del.)
Representing Lupin Limited in a Hatch-Waxman litigation in the District of Delaware concerning patents related to tolvaptan (the active ingredient in Otsuka’s Jynarque® product). Bench trial was completed in December 2023.
Baxter International, Inc. v. CyDex Pharmaceuticals, Inc., 21-0002-6106 (AAA)
Represented CyDex Pharmaceuticals in a contract dispute before the American Arbitration Association. Secured a complete victory for Cydex.
Rembrandt Diagnostics, LP. v. Alere, Inc., 2019-1595, 2019-1648 (C.A.F.C.)
Represented Rembrandt Diagnostics in an appeal before the Court of Appeals for the Federal Circuit. Secured a vacatur of adverse judgment against Rembrandt.
Kress v. OPMNY, LLC et al., 18-cv-3992 (S.D. Tex.).
Represented software designer Barry Kress in a lawsuit accusing his former employer of infringing his copyrights and misappropriating his trade secrets in new software code for processing credit card payments. Secured a favorable case-dispositive settlement after winning a motion to dismiss former employer’s counterclaims.
Aquastar Pool Products, Inc. v. Color Match Pool Fittings, Inc., 18-cv-94-JGB-SP (C.D. Cal.).
Represented leading pool drain designer Color Match Pool Fittings, Inc. in a patent-infringement lawsuit involving nine patents. Secured a favorable case-dispositive settlement after winning motions for summary judgment of patent invalidity and non-infringement.
Caire, Inc. v. Inogen, Inc., 16-cv-3413-ELR (N.D. Ga).
Successfully defended Inogen, Inc., a designer and manufacturer of portable oxygen concentrators, from an accusation of patent infringement. Secured a favorable case-dispositive settlement after challenging the asserted patent with an IPR petition before the U.S. Patent Trial and Appeal Board.
Gentherm Canada, ULC et al. v. IGB Automotive LTD, 13-11536 (E.D. Mich.).
Represented Gentherm Canada in a patent-infringement lawsuit and six IPR proceedings relating to automotive climate-control systems. Secured favorable case-dispositive settlement after successful IPR defense.
Desjardins et al. v. Wax et al., Patent Interference No. 105,915.
Represented Adam Wax in an interference proceeding before the U.S. Patent Trial and Appeal Board. The technology related to interferometers for detecting early-stage cancer. Favorable dispositive judgment secured for Mr. Wax.
Miller et al v. Richardson, Patent Interference No. 106,040.
Represented Robert Richardson in an interference proceeding before the U.S. Patent Trial and Appeal Board. The technology related to machines for removing industrial pollutants from air streams. Favorable dispositive judgment secured for Mr. Richardson.
Redline Detection, LLC v. Star EnviroTech, Inc. (IPR2013-00106).
Represented Star EnviroTech in one of the first IPR proceedings before the U.S. Patent Trial and Appeal Board. Successfully defended Star’s patent claims, making Star one of only a small percentage of patent holders to survive an early IPR challenge with all claims intact. Also represented Star on appeal before the U.S. Court of Appeals for the Federal Circuit (2015-1047), which upheld the U.S. Patent Trial and Appeal Board’s decision in a 33-page precedential decision.
AstraZeneca UK Limited. et al. v. Watson Labs., Inc. et al., Civ. No. 10-915 (D. Del.).
Represented Watson (now Actavis) in a patent infringement action relating to AstraZeneca’s Crestor® product. Case tried in 2012. Favorable case-dispositive settlement after trial.
AstraZeneca Pharm. et al. v. Cobalt Pharm., Inc. et al, Civ. No. 10-340 (D. Del.).
Represented Cobalt in a patent-infringement action relating to the use of AstraZeneca’s Crestor® product. Judgment for Cobalt dismissing all claims. Decision upheld on appeal.
AstraZeneca Pharm. LP et al. v. Handa Pharm., LLC, 08-cv-03773 (D.N.J.).
Represented Handa in a patent-infringement action relating to AstraZeneca’s Seroquel XR® product. Favorable case-dispositive settlement for Handa.
Salix Pharm. v. Novel Lab. et al., 3:08-cv-4628 (D.N.J.).
Represented Salix in a patent-infringement action relating to Salix’s OsmoPrep® product. Favorable case-dispositive settlement for Salix.
Masimo Corp. v. Respironics, 30-2008-00102827 (Cal. Sup. Ct.).
Represented Masimo in a lawsuit accusing its competitor of misappropriating trade secrets and breaching a contract relating to Masimo’s proprietary pulse oximeter products. Favorable case-dispositive settlement for Masimo.
Applied Medical Resources Corp. v. Gaya Ltd., 1:05-cv-8914 (C.D. Cal.).
Represented Applied in a patent-infringement action relating to devices for minimally invasive surgery. Favorable case-dispositive settlement for Applied.
Awards & Honors
- Recognized in Benchmark Litigation for his “exceptional” intellectual property litigation work (2021)
- Recognized in Benchmark Litigation's exclusive "Under 40 Hot List" for his work in intellectual property litigation (2018)
- Named a "Southern California Rising Star" by Super Lawyers magazine for his work in intellectual property litigation (2013-2019)
- Recognized as one of Southern California's "Rising Stars" in a survey published in Los Angeles magazine (2010-2011)